Patent · US Active

TLR7/8 antagonists and uses thereof

US10696649B2 · kind B2 · utility

2Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 26, 2019
Grant dateJun 30, 2020
Priority date—
Expiry dateNov 26, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula 1 and pharmaceutically acceptable compositions thereof are useful as TLR7/8 antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.